YOU ARE HERE:
Side-effects news
page  of 16
 
Headline
Date
  Need for vigilance: two cases of abacavir allergy despite pre-treatment screening all-clear
16.07.08
  One third of people with HIV have experienced sexual difficulties in the past month
15.07.08
  Important changes to nevirapine dosing advice made by FDA
03.07.08
  Acute kidney failure more common in people newly diagnosed with HIV
25.06.08
  Improvement in anaemia in majority of US patients after starting AZT reported in large review
24.06.08
  Impaired kidney function present in quarter of Zambians starting ART
05.06.08
  Low rate of toxicity-related treatment change suggests HIV treatment tolerable in the long-term
29.05.08
  Combining rifampicin with increased doses of lopinavir/ritonavir tablets leads to dangerous increases in liver enzymes
13.05.08
  Does tenofovir increase the risk of efavirenz-associated liver side-effects?
09.05.08
  Insulin resistance may predict risk of cardiovascular disease in HIV
08.05.08
  African-Americans with HIV have higher risk of aggressive kidney disease
07.05.08
  Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals
25.04.08
  Reducing d4T dose improves mitochondrial toxicity, but not lipoatrophy
16.04.08
  Abacavir remains an equal first for people starting HIV treatment in US
10.04.08
  Protease inhibitors increase fibrinogen levels: increased risk for hardening of the arteries
08.04.08
  GSK says its abacavir trials show no heart attack risk
02.04.08
  HLA-B*5701 test for abacavir hypersensitivity works equally well in black and white patients
01.04.08
  Start anti-HIV treatment with a CD4 cell count of 350 with efavirenz and Truvada, say draft British guidelines
01.04.08
  Most patients have a trusting relationship with their doctor after starting HIV drugs
31.03.08
  D:A:D finding that abacavir and ddI increase heart attack risk 'incomplete' say FDA
28.03.08

page  of 16